Cara Therapeutics Inc
Research Cara Therapeutics Inc (TVRD) on Bullrun: market cap USD 17.92M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTVRD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 17.92M
- Financial periodFY2025
- Net income-USD 18.21M
Valuation Snapshot
latest market cap is USD 17.92M.
About Cara Therapeutics Inc
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States.
Frequently asked questions
What is Cara Therapeutics Inc's market cap?
Cara Therapeutics Inc's market capitalization is USD 17.92M.
What does Cara Therapeutics Inc do?
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the...